SkinHealth Systems (SKIN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $10.56, -16.19% vs the prior close of $12.60.
- Volume 89.01K shares, 0.2x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
SKIN slides 16.2% to $10.56. Closed at $10.56, -16.19% vs the prior close of $12.60. Day range $10.30–$12.84, opened at $12.56.
SKIN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — SKIN slides 16.2% to $10.56
- Closed at $10.56, -16.19% vs the prior close of $12.60. Day range $10.30–$12.84, opened at $12.56.
- Volume was 89.01K shares, 0.2x its 50-day average of 363.90K — lighter than usual.
- Price is +862.6% vs its 50-day average ($1.10) and +949.3% vs its 200-day average ($1.01).
- 52-week range $0.50–$12.89; today's close sits at 81% of that range, 18.1% below the 52-week high.
Oct 15, 2026 — SKIN jumps 2190.9% to $12.60, a 52-week high
- Closed at $12.60, +2190.91% vs the prior close of $0.55. Day range $10.70–$12.89, opened at $11.31.
- Volume was 63.50K shares, 0.2x its 50-day average of 384.34K — lighter than usual.
- Price is +1300.3% vs its 50-day average ($0.90) and +1211.4% vs its 200-day average ($0.96).
- 52-week range $0.50–$12.89; today's close sits at 98% of that range, 2.2% below the 52-week high.
Oct 9, 2026 — SKIN slides 3.3% to $0.55, a 52-week low
- Closed at $0.55, -3.34% vs the prior close of $0.57. Day range $0.50–$0.55, opened at $0.52.
- Volume was 509.00K shares, 1.3x its 50-day average of 382.58K.
- Price is -16.9% vs its 50-day average ($0.66) and -39.2% vs its 200-day average ($0.91).
- 52-week range $0.50–$1.74; today's close sits at 4% of that range, 68.4% below the 52-week high.
Oct 8, 2026 — SKIN slides 3.6% to $0.57, a 52-week low
- Closed at $0.57, -3.56% vs the prior close of $0.59. Day range $0.55–$0.59, opened at $0.58.
- Volume was 397.70K shares, 1.0x its 50-day average of 392.46K.
- Price is -14.3% vs its 50-day average ($0.66) and -37.5% vs its 200-day average ($0.91).
- 52-week range $0.55–$1.76; today's close sits at 2% of that range, 67.7% below the 52-week high.
Oct 7, 2026 — SKIN rises 0.7% to $0.59
- Closed at $0.59, +0.68% vs the prior close of $0.59. Day range $0.57–$0.60, opened at $0.59.
- Volume was 219.40K shares, 0.5x its 50-day average of 408.71K — lighter than usual.
- Price is -11.4% vs its 50-day average ($0.67) and -35.5% vs its 200-day average ($0.91).
- 52-week range $0.55–$1.76; today's close sits at 3% of that range, 66.5% below the 52-week high.
Oct 6, 2026 — SKIN dips 2.3% to $0.59, a 3-month low, 4 down days in a row
- Closed at $0.59, -2.33% vs the prior close of $0.60. Day range $0.58–$0.63, opened at $0.63.
- Volume was 418.60K shares, 1.0x its 50-day average of 433.39K.
- Price is -12.2% vs its 50-day average ($0.67) and -36.3% vs its 200-day average ($0.92).
- 52-week range $0.55–$1.76; today's close sits at 3% of that range, 66.7% below the 52-week high.
- That makes 4 straight losses.
- SEC filings that day: 8-K.
Oct 5, 2026 — SKIN slides 4.8% to $0.60, a 1-month low, 3 down days in a row
- Closed at $0.60, -4.76% vs the prior close of $0.63. Day range $0.57–$0.64, opened at $0.63.
- Volume was 344.30K shares, 0.8x its 50-day average of 440.26K.
- Price is -10.6% vs its 50-day average ($0.67) and -35.1% vs its 200-day average ($0.92).
- 52-week range $0.55–$1.76; today's close sits at 4% of that range, 65.9% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — SKIN ends flat (+0.0%) to $0.63
- Closed at $0.63, +0.00% vs the prior close of $0.63. Day range $0.61–$0.65, opened at $0.61.
- Volume was 169.80K shares, 0.4x its 50-day average of 453.49K — lighter than usual.
- Price is -6.5% vs its 50-day average ($0.67) and -32.1% vs its 200-day average ($0.93).
- 52-week range $0.55–$1.81; today's close sits at 6% of that range, 65.2% below the 52-week high.
Oct 1, 2026 — SKIN ends flat (+0.0%) to $0.63
- Closed at $0.63, +0.00% vs the prior close of $0.63. Day range $0.62–$0.64, opened at $0.64.
- Volume was 352.50K shares, 0.8x its 50-day average of 456.13K.
- Price is -6.8% vs its 50-day average ($0.68) and -32.4% vs its 200-day average ($0.93).
- 52-week range $0.55–$1.98; today's close sits at 6% of that range, 68.2% below the 52-week high.
Sep 30, 2026 — SKIN rises 1.4% to $0.63
- Closed at $0.63, +1.45% vs the prior close of $0.62. Day range $0.61–$0.64, opened at $0.61.
- Volume was 205.00K shares, 0.4x its 50-day average of 469.71K — lighter than usual.
- Price is -7.1% vs its 50-day average ($0.68) and -32.7% vs its 200-day average ($0.94).
- 52-week range $0.55–$2.00; today's close sits at 5% of that range, 68.5% below the 52-week high.
Sep 29, 2026 — SKIN slides 4.5% to $0.62, a 1-month low
- Closed at $0.62, -4.46% vs the prior close of $0.65. Day range $0.61–$0.67, opened at $0.64.
- Volume was 228.40K shares, 0.5x its 50-day average of 478.92K — lighter than usual.
- Price is -8.8% vs its 50-day average ($0.68) and -33.9% vs its 200-day average ($0.94).
- 52-week range $0.55–$2.03; today's close sits at 5% of that range, 69.4% below the 52-week high.
SKIN latest news & SEC filings
Every SEC filing by or about SKIN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.03 — Change to shareholder rights.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Oct 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Malha Pedro Bruno Ferreira had withheld for taxes 99,742 shares at $0.55 (≈$54.86K) on Oct 9, 2026; now holds 4,745,509
- Malha Pedro Bruno Ferreira had withheld for taxes 78,045 shares at $0.55 (≈$42.92K) on Oct 9, 2026; now holds 4,667,464
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.02 — Ended a material agreement.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Sep 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 12, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 12, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Aug 12, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $72.11M (prior year $78.19M) (-7.8% vs Jun 30, 2025)
- Net income: -$2.67M (prior year $19.71M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.02 (prior year $0.03) (loss widened vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 31, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Jul 27, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 17, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade SKIN
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Mar 12, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 111.78% (largest 2190.9%). That is a volatile stock.
- Liquidity: about 314.64K shares (≈$3.32M) trade per day on average.
- 52-week position: $10.56 vs a range of $0.50–$12.89 (81% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:20 on Oct 14, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 14, 2026; 8-K Oct 6, 2026; 8-K Sep 28, 2026.
- Share count: 130.14M shares outstanding (Aug 3, 2026), +2.6% vs a year earlier.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
SKIN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 12.56 | 12.84 | 10.30 | 10.56 | 89.01K |
| Oct 15, 2026 | 11.31 | 12.89 | 10.70 | 12.60 | 63.50K |
| Oct 9, 2026 | 0.52 | 0.55 | 0.50 | 0.55 | 509.00K |
| Oct 8, 2026 | 0.58 | 0.59 | 0.55 | 0.57 | 397.70K |
| Oct 7, 2026 | 0.59 | 0.60 | 0.57 | 0.59 | 219.40K |
| Oct 6, 2026 | 0.63 | 0.63 | 0.58 | 0.59 | 418.60K |
| Oct 5, 2026 | 0.63 | 0.64 | 0.57 | 0.60 | 344.30K |
| Oct 2, 2026 | 0.61 | 0.65 | 0.61 | 0.63 | 169.80K |
| Oct 1, 2026 | 0.64 | 0.64 | 0.62 | 0.63 | 352.50K |
| Sep 30, 2026 | 0.61 | 0.64 | 0.61 | 0.63 | 205.00K |
| Sep 29, 2026 | 0.64 | 0.67 | 0.61 | 0.62 | 228.40K |
| Sep 28, 2026 | 0.65 | 0.69 | 0.64 | 0.65 | 211.10K |
| Sep 25, 2026 | 0.65 | 0.68 | 0.64 | 0.67 | 180.20K |
| Sep 24, 2026 | 0.67 | 0.67 | 0.65 | 0.66 | 248.50K |
| Sep 23, 2026 | 0.66 | 0.68 | 0.64 | 0.68 | 247.70K |
| Sep 22, 2026 | 0.65 | 0.68 | 0.65 | 0.67 | 267.10K |
| Sep 21, 2026 | 0.67 | 0.70 | 0.64 | 0.68 | 387.80K |
| Sep 18, 2026 | 0.67 | 0.69 | 0.65 | 0.68 | 1.03M |
| Sep 17, 2026 | 0.68 | 0.70 | 0.64 | 0.68 | 260.90K |
| Sep 16, 2026 | 0.66 | 0.69 | 0.64 | 0.68 | 463.90K |
About SkinHealth Systems
SkinHealth Systems (SKIN) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in LONG BEACH, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1818093.
SKIN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Edward Scott Beattie | Director | Apr 22, 2026 |
| Pedro Bruno Ferreira Malha | President and CEO | Mar 24, 2026 |
| Philippe Schaison | Director | Nov 17, 2025 |
| Sachin Mahavir Shridharani | Director | Apr 22, 2026 |
| Kenneth Robert Tripp | Director | Apr 22, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Sheri Lewis | CSO and COO | Apr 13, 2026 |
| Michael P. Monahan | Chief Financial Officer | Aug 12, 2026 |
| Pedro Bruno Ferreira Malha | President and CEO | Mar 24, 2026 |
| Ronald Menezes | Chief Revenue Officer | Mar 24, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
SKIN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $300.79M | $-9.52M | -0.16 | $37.48M |
| Dec 31, 2024 | $334.29M | $-29.10M | -0.36 | $16.13M |
| Dec 31, 2023 | $397.99M | $-100.12M | -0.76 | $21.75M |
| Dec 31, 2022 | $365.88M | $44.22M | -0.23 | $-106.60M |
| Dec 31, 2021 | $260.09M | $-378.76M | -3.71 | $-28.36M |
Latest balance sheet: total assets $486.57M, total liabilities $431.00M, cash $523.02M (as of Jun 30, 2026).
SKIN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $0.77 |
| May 7, 2026 | 8-K Item 2.02 (results) | $0.91 |
| Mar 12, 2026 | 8-K Item 2.02 (results) | $1.06 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $1.29 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $1.59 |
| May 8, 2025 | 8-K Item 2.02 (results) | $1.24 |
| Mar 12, 2025 | 8-K Item 2.02 (results) | $1.42 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $1.70 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Mar 12, 2024 | 8-K Item 2.02 (results) | — |
| Nov 13, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on SKIN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.